Del. Judge Finds Teva Infringed ADHD Drug IP On Remand
A Teva unit infringed five valid Tris Pharma Inc. patents when applying to sell a generic version of the ADHD treatment Quillivant XR, a Delaware federal judge has ruled in an...To view the full article, register now.
Already a subscriber? Click here to view full article